ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Takaaki Suzuki
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamichi, T.
Right arrow Articles by Morikawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamichi, T.
Right arrow Articles by Morikawa, Y.

Ann Thorac Surg 1997;63:1160-1161
© 1997 The Society of Thoracic Surgeons


Case Report

Primary Cardiac Angiosarcoma: 53 Months' Survival After Multidisciplinary Therapy

Tsukasa Nakamichi, MD, Toyoki Fukuda, MD, Takaaki Suzuki, MD, Takashi Kaneko, MD, Yukihiko Morikawa, MD

Division of Cardiovascular Surgery and Departments of Pediatrics, and Pathology, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan

Accepted for publication November 6, 1996.


    Abstract
 Top
 Footnotes
 Abstract
 Introduction
 Comment
 References
 
An 8-year-old girl underwent surgical excision of a tumor arising from the right atrium immediately after admission. Because histologic and immunohistochemical examination confirmed the diagnosis of angiosarcoma, adjunctive multidisciplinary therapy was administered for the following 2 years. She is leading a normal school life 53 months after the operation. Therapeutic strategy for this highly malignant cardiac tumor is discussed.


    Introduction
 Top
 Footnotes
 Abstract
 Introduction
 Comment
 References
 
Primary cardiac angiosarcoma is a rare malignant cardiac tumor and is known to carry a high mortality rate due to its rapid local relapse and high incidence of systemic metastasis. Because of nonspecific clinical presentation, most of the diagnoses in previous reports were made either at autopsy or shortly before the patients' deaths [1]. Recent advances of diagnostic methods have allowed antemortem diagnosis to be made and the patients to be treated with a therapeutic strategy including surgical excision of the tumor [2]. Early death by invariably rapid local relapse or systemic metastasis, however, is the rule, and only a few long-term survivors have been reported, thus hindering establishment of an optimal therapeutic strategy.

An 8-year-old girl was admitted to our hospital with complaints of fever, nonproductive cough, and orthopnea. On physical examination she was severely dyspneic at rest. The liver was palpable 3 cm below the right costal margin but without evidence of dependent edema. Chest roentgenography showed a markedly enlarged cardiac silhouette, with a cardiothoracic ratio of 0.75. Electrocardiography revealed regular sinus rhythm. Two-dimensional echocardiography disclosed a space-occupying tumor in the right atrium and a large amount of fluid in the pericardial sac. Computed tomography clearly demonstrated an inhomongeneously enhanced mass, 8 cm in diameter, in the right side of the cardiac silhouette. Whole-body gallium scintigraphy showed no evidence of systemic metastasis. The patient underwent pericardiocentesis and bloody fluid was aspirated, in which no atypical cell was found. Left ventriculography revealed hypokinesis of the anterolateral wall with an ejection fraction of 0.42. Selective right coronary angiography demonstrated tumor stain in the right atrial region with feeding arteries arising from segment 2 and a cluster of small arteries near segment 4. In contrast to the cytologic findings of the pericardial fluid, all these findings suggested malignancy of the tumor, thus prompting us to proceed to surgical excision on the 6th day of admission.

When the pericardium was opened, the tumor extended from the right atrial free wall to the right anterior pericardium. With the aid of cardiopulmonary bypass and moderate hypothermia, we resected the tumor mass including the tightly adhered pericardium and surrounding atrial free wall, and reconstructed the atrial wall defect with a bovine pericardial patch. Excision was inevitably incomplete near the sinoatrial node and right atrioventricular groove. Postoperative recovery was uneventful, and the electrocardiogram returned to regular sinus rhythm after a brief period of second-degree atrioventricular block.

The excised tumor was round, measured 90 x 50 x 40 mm, and weighed 115 g. The cut surface was dark red and revealed variously sized foci of hemorrhage and necrosis (Fig 1Go). Histologic examination showed abnormal proliferation of atypical plump endothelial cells that formed sinusoidal arrangements of various sizes. In some sites the stroma was scanty and dominated by spindle-shaped cells, and in the other sites solid sheets of anaplastic pleomorphic cells, with numerous mitotic figures, were observed. Immunohistochemical stainings of the cells were positive for factor VIII and negative for myoglobin and desmin, which reconfirmed the histologic diagnosis of angiosarcoma. Systemic immunochemotherapy was initiated immediately after the operation. The therapeutic regimen was a combination of chemotherapy that comprised dacarbazine, THP-doxorubicin, and ifosfamide for a week and immunotherapy with interleukin II for the following 2 weeks (Table 1Go). This regimen was repeated monthly. Irradiation therapy was also added, with a total dose of 50 Gy. At completion of nine cycles of immunochemotherapy, ie, when the accumulated dose of THP-doxorubicin reached 390 mg/m2, however, the patient became intolerant to the therapy due to impaired cardiac function, with an ejection fraction of 0.61 and appearance of grade 2 tricuspid regurgitation. After discontinuation of THP-doxorubicin administration cardiac function reverted to normal, with grade 1 tricuspid regurgitation, thereby allowing two more cycles of immunochemotherapy excluding THP-doxorubicin. At completion of 11 cycles of immunochemotherapy and 1 year after the operation, the patient was discharged and received seven more cycles every other month for the following 1-year period. Repeat cardiac catheterization, performed a year after completion of the entire therapeutic regimen, revealed normal pressures of the four cardiac chambers and normal ventricular function. The patient is now leading a normal school life 53 months after the operation, without any evidence of local relapse or systemic metastasis.



View larger version (175K):
[in this window]
[in a new window]
 
Fig 1. . The excised tumor was round, measured 90 x 50 x 40 mm, and weighed 115 g. The cut surface was dark red and revealed variously sized foci of hemorrhage and necrosis.

 

View this table:
[in this window]
[in a new window]
 
Table 1. . Regimen of Chemotherapy and Immunotherapya
 

    Comment
 Top
 Footnotes
 Abstract
 Introduction
 Comment
 References
 
Recent advances of imaging diagnostic methods have allowed antemortem diagnoses of cardiac tumors and aggressive therapeutic strategies comprising extensive surgical excision and postoperative multidisciplinary therapy. Because of highly aggressive malignancy of primary cardiac angiosarcoma, various chemotherapeutic regimens have been employed as adjuncts to the surgical therapy. Most frequently used are the combinations of cyclophosphamide, doxorubicin, vincristine, dacarbazine, and of dacarbazine or mitomycin C, doxorubicin, vincristine, and cisplatin [2]. Preoperative chemotherapy combined with irradiation is reported to be beneficial in reducing the size of the tumor [3], whereas others have pointed out severe cardiac toxicity in the combination of irradiation and anthracycline-based regimens and are rather reluctant to use radiation therapy, particularly for patients who already had impaired cardiac function [4]. Despite aggressive attempts at preoperative and postoperative management, most of the patients in previous reports succumbed within 9 months after the operation, and long-term survivors have been rare. Be that as it may, the patients reported by Sorlie and associates [5], Percy and colleagues [6], and us, all of whom are free from symptoms for more than 34 months after operation, suggest a favorable outlook for therapeutic strategies against primary cardiac angiosarcoma. Common features among these long-term survivors are extensive surgical resection of the tumor accompanied by adjunctive multidisciplinary therapy and absence of systemic metastasis at the time of the operation. In the context of rapid growth and early metastasis, which characterize primary cardiac angiosarcoma, our favorable outcome may implicate the importance of early detection and immediate initiation of an aggressive therapeutic strategy. The combination and mode of initiation of the multidisciplinary therapy, however, may require further investigation.


    Footnotes
 Top
 Footnotes
 Abstract
 Introduction
 Comment
 References
 
Address reprint requests to Dr Nakamichi, Division of Cardiovascular Surgery, Department of Surgery, Keio University, 35 Shinanomachi, Shinjuku, Tokyo 160, Japan.


    References
 Top
 Footnotes
 Abstract
 Introduction
 Comment
 References
 

  1. Janigan DT, Husain A, Robinson NA. Cardiac angiosarcomas: a review and a case report. Cancer 1986;57:852–9.[Medline]
  2. Herrmann MA, Shankerman RA, Edwards WD, Shub C, Schaff HV. Primary cardiac angiosarcoma: a clinicopathologic study of six cases. J Thorac Cardiovasc Surg 1992;103:655–64.[Abstract]
  3. Baay P, Karwande SV, Kushner JP, Olsen S, Renlund DG. Successful treatment of a cardiac angiosarcoma with combined modality therapy. J Heart Lung Transplant 1994;13:923–5.[Medline]
  4. Stein M, Deitling F, Cantor A, Perner Y, Bezwoda W. Primary cardiac angiosarcoma: a case report and review of therapeutic options. Med Pediatr Oncol 1994;23:149–52.[Medline]
  5. Sorlie D, Myhre ESP, Stalsberg H. Angiosarcoma of the heart: unusual presentation and survival after treatment. Br Heart J 1984;51:94–7.[Abstract/Free Full Text]
  6. Percy RF, Perryman RA, Amornman R, et al. Prolonged survival in a patient with primary angiosarcoma of the heart. Am Heart J 1987;113:1228–30.[Medline]



This article has been cited by other articles:


Home page
Journal of the American Animal Hospital AssociationHome page
M. Morges, D. R. Worley, S. J. Withrow, and E. Monnet
Pericardial Free Patch Grafting as a Rescue Technique in Surgical Management of Right Atrial HSA
J. Am. Anim. Hosp. Assoc., May 1, 2011; 47(3): 224 - 228.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. P. Kim, A. M. Correa, S. Blackmon, G. Quiroga-Garza, D. Weilbaecher, B. Bruckner, B. Ramlawi, D. C. Rice, A. A. Vaporciyan, and M. J. Reardon
Outcomes After Right-Side Heart Sarcoma Resection
Ann. Thorac. Surg., March 1, 2011; 91(3): 770 - 776.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
M. Nakamura-Horigome, J. Koyama, T. Eizawa, H. Kasai, S. Kumazaki, H. Tsutsui, K. Koiwai, K. Oguchi, O. Kinoshita, and U. Ikeda
Successful Treatment of Primary Cardiac Angiosarcoma With Docetaxel and Radiotherapy
Angiology, July 1, 2008; 59(3): 368 - 371.
[Abstract] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
J. Canadyova, M. Setina, S. Smetanova, and A. Mokracek
Leiomyosarcoma of the Left Atrium
Asian Cardiovasc Thorac Ann, February 1, 2008; 16(1): e7 - e9.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Totaro, F. Miraldi, C. Ghiribelli, and C. Biscosi
Cardiac Angiosarcoma Arising From Pulmonary Artery: Endovascular Treatment
Ann. Thorac. Surg., October 1, 2004; 78(4): 1468 - 1470.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C H Lee, G S W Chan, and W M Chan
Unexplained recurrent pericardial effusion: a lethal warning?
Heart, March 1, 2003; 89(3): e11 - 11.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Takaaki Suzuki
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamichi, T.
Right arrow Articles by Morikawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamichi, T.
Right arrow Articles by Morikawa, Y.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS